NCT05600868

Brief Summary

Research to date indicates that trauma-focused treatments are safe and effective for PTSD, even when higher-risk comorbidities (e.g., psychosis or substance use) are present. In particular, there are data pointing to the efficacy of prolonged exposure therapy and eye movement desensitization and reprocessing (EMDR) therapy. Clinical practice guidelines specifically recommend trauma-focused treatment with exposure and/or cognitive restructuring components. Regarding EMDR interventions, there are increasing results supporting its efficacy. Some interesting clinical advantages presented by EMDR as opposed to cognitive-behavioral therapies are 1) the efficacy found despite less exposure to the traumatic memory, 2) the exclusion of homework, 3) as well as the rapid reduction in subjective disturbance produced even after a single session of EMDR therapy. However, the mechanisms producing the improvement and, in particular, the effect of bilateral stimulation are not precisely known. More research is needed in this regard since bilateral stimulation is the most controversial part and with less evidence found. In addition to this, there are very few studies that have analyzed the differential efficacy of the presence or absence of bilateral stimulation or of the different types of stimulation possible. As for the comparison between types of stimulation (bilateral with eye movements, or focusing on a fixed point), greater treatment effects have been found for EMDR with fixation on an immobile hand compared to eye movements. The aim of this study is to examine the effectiveness of a comprehensive intervention protocol for people who have experienced traumatic events and present post-traumatic symptomatology. In addition, this study will compare the efficacy of traumatic memory processing with and without dual attention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Sep 2022Dec 2026

Study Start

First participant enrolled

September 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 1, 2022

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 25, 2025

Status Verified

April 1, 2025

Enrollment Period

3.7 years

First QC Date

October 26, 2022

Last Update Submit

April 22, 2025

Conditions

Keywords

TraumaTraumatic Stress DisorderEMDRDual Attention

Outcome Measures

Primary Outcomes (3)

  • Change from posttraumatic symptoms at 10 weeks and 6 months

    International Trauma Questionnaire (ITQ; Cloitre et al., 2018). Higher scores mean a worse outcome.

    Change baseline, 10 weeks, and 6 months

  • Change from psychopathological symptoms at 10 weeks and 6 months

    Symptom Checklist 45-SCL-90R brief (Davison et al., 1997).Higher scores mean a worse outcome.

    Change baseline, 10 weeks, and 6 months

  • Change from Dissociative symptoms at 10 weeks and 6 months

    Dissociative Experience Scale DES II (Carlson and Putnam, 1993). Higher scores mean a worse outcome.

    Change baseline, 10 weeks, and 6 months

Secondary Outcomes (4)

  • Change from Well-being at 10 weeks and 6 months

    Change baseline, 10 weeks, and 6 months

  • Change from Satisfaction with life at 10 weeks and 6 months

    Change baseline, 10 weeks, and 6 months

  • Change from Emotion Regulation at 10 weeks and 6 months

    Change baseline, 10 weeks, and 6 months

  • Change from Attachment style at 10 weeks and 6 months

    Change baseline, 10 weeks, and 6 months

Study Arms (3)

EMDR+dual attention

ACTIVE COMPARATOR

.Processing the trauma with exposition and dual attention.

Behavioral: A comprehensive third-generation intervention EMDR + dual attention

EMDR + fixed point

ACTIVE COMPARATOR

Processing the trauma with exposition and fixed point.

Behavioral: A comprehensive third-generation intervention EMDR + fixed point

EMDR + exposition

ACTIVE COMPARATOR

Processing the trauma with exposition.

Behavioral: A comprehensive third-generation intervention EMDR + dual attentionBehavioral: A comprehensive third-generation intervention EMDR + exposition

Interventions

This is a individual intervention with a total of 10 sessions. In the processing the traumatic event phase will be realized with double attention.

EMDR + expositionEMDR+dual attention

This is a individual intervention with a total of 10 sessions. In the processing the traumatic event phase will be realized with fixed point.

EMDR + fixed point

This is a individual intervention with a total of 10 sessions. In the processing the traumatic event phase will be realized with exposition.

EMDR + exposition

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be between the ages of 18 and 65 fluent enough in Spanish language; 2.

You may not qualify if:

  • Present severe active suicidal ideation, or have made a self-injurious attempt during the last month.
  • Present a diagnosis of substance dependence, intellectual disability or severe cognitive dysfunction.
  • Having received EMDR treatment in the last 6 months.
  • Also excluded from the program are those people who cannot guarantee continuity in the therapeutic process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmen Valiente

Pozuelo de Alarcón, Madrid, 28223, Spain

Location

MeSH Terms

Conditions

Psychological TraumaStress Disorders, TraumaticWounds and Injuries

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2022

First Posted

November 1, 2022

Study Start

September 1, 2022

Primary Completion

April 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 25, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations